Nuvation Bio Inc.
NUVBNYSECIK 1811063HealthcareFiscal year ends Dec 31
Reports and events: 105 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-2716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-283346 |
| 2023-11-1316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-276021 |
| 2023-11-0216:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-269399 |
| 2023-11-0216:21 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058253 |
| 2023-08-0317:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-038155 |
| 2023-08-0316:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-202881 |
| 2023-05-1616:03 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-146073 |
| 2023-05-0416:29 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-017926 |
| 2023-05-0416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-135935 |
| 2023-04-0416:05 ET | DEF 14A | Proxy statementPeriod 2023-05-15 | 0001140361-23-016216 |
| 2023-03-1516:35 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-008180 |
| 2023-03-1516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-071350 |
| 2023-03-0216:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-058263 |
| 2023-02-1316:40 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-035949 |
| 2022-12-2316:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-311807 |
| 2022-11-0316:38 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021943 |
| 2022-11-0316:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-276899 |
| 2022-08-0417:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014868 |
| 2022-08-0416:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-212548 |
| 2022-08-0108:31 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events | 0001193125-22-207816 |
| 2022-05-1716:36 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-153069 |
| 2022-05-0916:33 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-008530 |
| 2022-05-0916:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-145022 |
| 2022-04-0416:01 ET | DEF 14A | Proxy statementPeriod 2022-05-16 | 0001140361-22-012878 |
| 2022-02-2817:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-058273 |
| 2022-02-2817:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002332 |
| 2022-01-1017:09 ET | 8-K | 2.02 Results of operations | 0001193125-22-005788 |
| 2022-01-1006:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-004997 |
| 2021-11-1016:19 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004093 |
| 2021-11-1016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-325991 |
| 2021-10-2816:16 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-21-311319 |
| 2021-08-1216:48 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001385 |
| 2021-08-1216:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-244709 |
| 2021-06-0416:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-182967 |
| 2021-05-2116:04 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001193125-21-169245 |
| 2021-05-1717:17 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000950170-21-000267 |
| 2021-05-1717:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-163866 |
| 2021-05-1416:47 ET | 8-K | 4.02 Non-reliance on financial statements | 0001193125-21-162123 |
| 2021-03-2917:07 ET | S-1/A | Registration statement, amended | 0001193125-21-098442 |
| 2021-03-1117:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-077969 |
| 2021-03-1117:07 ET | S-1 | Registration statement | 0001193125-21-077946 |
| 2021-03-1116:59 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-21-077931 |
| 2021-03-1116:38 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001193125-21-077880 |
| 2021-02-1916:18 ET | SC 13D | Ownership report, active investor | 0001193125-21-048965 |
| 2021-02-1916:14 ET | SC 13D | Ownership report, active investor | 0001193125-21-048950 |
| 2021-02-1217:22 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001193125-21-041929 |
| 2021-02-0917:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-21-034624 |
| 2020-11-1610:00 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-037163 |
| 2020-10-2109:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-20-032470 |
| 2020-08-2017:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-023121 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 17:21 ET. Listed shows no prices and gives no investment advice.